Novavax, bolstered by $1.6 billion in federal funding, is unlikely to seek emergency use authorization for its experimental coronavirus vaccine in the United States until July at the earliest, the …
https://www.washingtonpost.com/health/2021/05/10/novavax-coronavirus-vaccine/

